Generex Biotechnology (Nasdaq: GNBT) has reviewed the positive data from its bioequivalent study with MetControl, its proprietary metformin chewing gum ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE